Studies using oral glucose tolerance tests (OGTT) have shown that impaired glucose metabolism presents in the early stages of schizophrenia (SCZ). However, there is a lack of studies on changes in glucose metabolism with the stage of the disease. We first explored the features of glucose metabolic pattern at different phases of male SCZ. We recruited 83 male first episode drug-naïve patients with SCZ (FEDN-SCZ) and 64 male chronic patients with SCZ (CH-SCZ), as well as 14 male healthy controls. The Positive and Negative Syndrome Scale (PANSS) was used to assess the psychopathology of patients. OGTT, fasting plasma glucose and lipid profiles of all participants were examined. While the impaired glucose tolerance (IGT) rate of male SCZ patients was higher than that of HC (P< .05), there was no difference in IGT prevalence between FEDN-SCZ and CH-SCZ. In male FEDN-SCZ, LDL (OR=2.64, 95% CI=1.11-6.29, P= .028) and PANSS total score (OR=1.03, 95% CI=1.00-1.06, P= .046) were positively correlated with IGT; in male CH-SCZ, BMI (OR=1.7, 95% CI=1.08-2.67, P= .023), PANSS total score (OR=0.82, 95% CI=0.70-0.96, P= .015) and positive symptoms (OR=0.45, 95% CI=0.20-0.99, P= .046) were significantly correlated with IGT. Our findings reflect different glucose metabolism patterns in different stages of SCZ.